Your browser doesn't support javascript.
loading
Canine amniotic membrane-derived mesenchymal stem cells ameliorate atopic dermatitis through regeneration and immunomodulation.
Kim, Min Soo; Kong, Dasom; Han, Myounghee; Roh, Kyounghwan; Koo, Hojun; Lee, Seunghee; Kang, Kyung-Sun.
Afiliação
  • Kim MS; Adult Stem Cell Research Center, Research Institute for Veterinary Science, College of Veterinary Medicine, Seoul National University, Seoul, 08826, Republic of Korea.
  • Kong D; Adult Stem Cell Research Center, Research Institute for Veterinary Science, College of Veterinary Medicine, Seoul National University, Seoul, 08826, Republic of Korea.
  • Han M; Department of Agricultural Biotechnology and Research Institute of Agriculture and Life Sciences, Seoul National University, Seoul, 08826, Republic of Korea.
  • Roh K; Stem Cell and Regenerative Bioengineering Institute, Global R&D Center, Kangstem Biotech Co. Ltd, Ace Highend Tower 8, 84, Gasan digital 1-ro, Geumcheon-gu, Seoul, 08590, Republic of Korea.
  • Koo H; Smile Veterinary Clinic, Jungbu-daero, Cheoin-gu, yongin-si, Gyeonggi-do, 1510, Republic of Korea.
  • Lee S; Stem Cell and Regenerative Bioengineering Institute, Global R&D Center, Kangstem Biotech Co. Ltd, Ace Highend Tower 8, 84, Gasan digital 1-ro, Geumcheon-gu, Seoul, 08590, Republic of Korea.
  • Kang KS; Adult Stem Cell Research Center, Research Institute for Veterinary Science, College of Veterinary Medicine, Seoul National University, Seoul, 08826, Republic of Korea. kangpub@snu.ac.kr.
Vet Res Commun ; 47(4): 2055-2070, 2023 Dec.
Article em En | MEDLINE | ID: mdl-37421548

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transplante de Células-Tronco Mesenquimais / Dermatite Atópica / Doenças do Cão / Células-Tronco Mesenquimais Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transplante de Células-Tronco Mesenquimais / Dermatite Atópica / Doenças do Cão / Células-Tronco Mesenquimais Idioma: En Ano de publicação: 2023 Tipo de documento: Article